U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07784712) titled 'Right Ventricular Septal Biopsy to Detect Cardiac Amyloidosis' on Aug. 21.
Brief Summary: People eligible for this study have had the suggestion from their doctor to receive a cardiac pacemaker or defibrillator to treat a cardiac condition as part of their routine care. We are doing this study to understand if obtaining a tissue sample from their body during a device implant may assist in the early diagnosis of Transthyretin Cardiac Amyloidosis (ATTR-CM).
Study Start Date: Oct., 2026
Study Type: OBSERVATIONAL
Condition:
ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
Heart Failure
Recruitment Status: NOT_YET_RECRUITING
Sponsor:...